The company secures a Beta (Market Risk) of 0.7225, which conveys possible diversification benefits within a given portfolio. Let's try to break down what Neogen's beta means in this case. As returns on the market increase, Neogen Cp returns are expected to increase less than the market. However, during the bear market, the loss on holding Neogen Cp will be expected to be smaller as well. Even though it is essential to pay attention to
Neogen Cp price patterns, it is always good to be careful when utilizing equity historical
price patterns. Our philosophy towards estimating any stock's
future performance is to check both, its past performance charts as well as the business as a whole, including all available
technical indicators. Neogen Cp exposes twenty-eight different technical indicators, which can help you to evaluate its performance.
Neogen Cp has an expected return of -0.1%. Please be advised to verify Neogen Cp
downside variance, and the
relationship between the
treynor ratio and
kurtosis to decide if
Neogen Cp performance from the past will be repeated at some point in the near future.
Annual and quarterly reports issued by Neogen are formal
financial statements that are published yearly and quarterly and sent to Neogen stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the
Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as Neogen often view their annual report as an effective marketing tool to disseminate their perspective on company
future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.
Neogen
financial leverage refers to using borrowed capital as a funding source to finance Neogen ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Neogen financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Neogen's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Neogen's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Neogen's total debt and its cash.
Is Neogen a risky opportunity?
Let's check the volatility. Neogen is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Neogen (NASDAQ:NEOG) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. purchasing a share of a Neogen Cp stock makes you a part-owner of that company.
Neogen Cp Current Consensus
Here is the latest trade recommendation based on an ongoing consensus estimate among financial analysis covering Neogen Cp. The Neogen consensus assessment is calculated by taking the average estimates from all of the analysts covering Neogen Cp
| Strong Buy | 1 | 33.33 |
| Buy | 0 | 0.0 |
| Hold | 2 | 66.67 |
| Sell | 0 | 0.0 |
| Strong Sell | 0 | 0.0 |
Neogen showing appearance of lower volatility
Latest Risk Adjusted Performance is up to -0.04. Price may dip again. Neogen Cp exhibits very low volatility with skewness of -0.12 and kurtosis of 0.11. However, we advise investors to further study Neogen Cp technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Neogen Cp's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Neogen Cp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Takeaway on Neogen Cp Investment
Although some other companies under the diagnostics & research industry are still a bit expensive, Neogen Cp may offer a potential longer-term growth to shareholders. To conclude, as of the 16th of July 2021, our research shows that Neogen Cp is a rather very steady investment opportunity with a
close to average odds of financial turmoil in the next two years. From a slightly different view, the entity currently appears to be
fairly valued. Our latest 90 days recommendation on the firm is
Strong Hold.
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Neogen. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com